{"id":"NCT02431806","sponsor":"Forest Laboratories","briefTitle":"Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder","officialTitle":"A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-23","primaryCompletion":"2019-08-19","completion":"2019-08-19","firstPosted":"2015-05-01","resultsPosted":"2020-09-07","lastUpdate":"2020-09-07"},"enrollment":552,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Levomilnacipran","otherNames":["Fetzima"]},{"type":"DRUG","name":"Fluoxetine","otherNames":["Prozac"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Levomilnacipran 40 mg","type":"EXPERIMENTAL"},{"label":"Levomilnacipran 80 mg","type":"EXPERIMENTAL"},{"label":"Fluoxetine 20 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.","primaryOutcome":{"measure":"Change From Baseline in Children's Depression Rating Scale-Revised (CDRS-R) Total Score","timeFrame":"Baseline (Week 0) to Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-22.9,"sd":1.09},{"arm":"Levomilnacipran 40 mg/Day","deltaMin":-23.28,"sd":1.11},{"arm":"Levomilnacipran 80 mg/Day","deltaMin":-22.64,"sd":1.12},{"arm":"Fluoxetine 20 mg/Day","deltaMin":-24.37,"sd":1.12}],"pValues":[{"comp":"OG000 vs OG001","p":"0.8035"},{"comp":"OG000 vs OG002","p":"0.8681"},{"comp":"OG000 vs OG003","p":"0.3439"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":49,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["38700708"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":141},"commonTop":["Headache","Nausea","Tachycardia","Vomiting","Decreased appetite"]}}